Drug intelligence / Profile preview

Lactobacillus oris

Development stage
Preclinical
Modality
Live Biotherapeutic Products → Microbiome Therapeutics
Administration
Oral
01

Overview

*Lactobacillus oris* is a species of Gram-positive, non-spore-forming lactic acid bacteria naturally found in the human oral cavity, breast milk, and gastrointestinal tract. It is being investigated as a potential probiotic for various health applications. Research indicates that specific strains of *L. oris* possess lipid-lowering properties, potentially reducing cholesterol levels by inhibiting 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) and modulating the FXR-FGF15 signaling pathway. It has also shown promise in improving non-alcoholic fatty liver disease (NAFLD) and enhancing intestinal barrier function through the activation of the pregnane X receptor (PXR). In the context of oral health, *L. oris* exhibits antimicrobial activity against pathogens like *Streptococcus mutans* and *Porphyromonas gingivalis*. While primarily considered a commensal or beneficial organism, some studies have noted its ability to aggregate platelets, suggesting a potential role in the progression of infective endocarditis in susceptible individuals.

Other names
L. oris
02

Targets

HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)FXR (Farnesoid x-activated receptor)PXR (Pregnane X receptor)

Beyond the preview

Go deeper on Lactobacillus oris.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lactobacillus oris.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call